The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hack, C. E.
Right arrow Articles by Van Milligen, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hack, C. E.
Right arrow Articles by Van Milligen, F.

The Journal of Immunology, Vol 144, Issue 11 4249-4255, Copyright © 1990 by American Association of Immunologists

ARTICLES

Demonstration in human plasma of a form of C3 that has the conformation of "C3b-like C3"

CE Hack, J Paardekooper and F Van Milligen
Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam.

Disruption of the thioester in native C3 yields a C3 molecule that functionally resembles C3b. It has been proposed that this C3 molecule (iC3) plays a key role in initiation of the alternative pathway of the C system. However, its presence in plasma has never been demonstrated. We investigated the presence of iC3 in plasma, using mAb that recognize iC3 as well as C3 activation products but not native C3. One of these mAb, anti-C3-5, which binds iC3 via its C3a moiety, was used together with polyclonal 125I-anti-C3c to develop a RIA for iC3. Plasma incubated with methylamine yielded a strong response in this RIA, whereas neither fresh plasma nor serum in which the C system had been activated by incubation with aggregated IgG, did show this strong response. The specificity of this RIA was further demonstrated by additional experiments including experiments with purified preparations of the various forms of C3. Mean level of iC3 in freshly obtained plasma samples from 10 normal donors was 27 nmol/liter, which is 0.49% of total C3. Analysis by SDS-PAGE of C3 species that had been immunoprecipitated by mAb antiC3-5, revealed that some iC3 consisted of C3 molecules with an intact alpha-chain whereas another part consisted of iC3 molecules with an alpha-chain that had been cleaved by factor I. Thus, this study shows that fresh human plasma contains a C3 species with the conformation of "C3b-like C3" (iC3).


This article has been cited by other articles:


Home page
 J. Immunol.Home page
J. Andersson, K. N. Ekdahl, R. Larsson, U. R. Nilsson, and B. Nilsson
C3 Adsorbed to a Polymer Surface Can Form an Initiating Alternative Pathway Convertase
J. Immunol., June 1, 2002; 168(11): 5786 - 5791.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
G. Hetland, O. Moen, K. Bergh, K. Hogasen, C. E. Hack, T. E. Mollnes, and E. Fosse
Both Plasma- and Leukocyte-Associated C5a Are Essential for Assessment of C5a Generation In Vivo
Ann. Thorac. Surg., April 1, 1997; 63(4): 1076 - 1080.
[Abstract] [Full Text]

Home page
 Ann. Thorac. Surg.Home page
O. Moen, K. Hogasen, E. Fosse, E. Dregelid, V. Brockmeier, P. Venge, M. Harboe, and T. E. Mollnes
Attenuation of Changes in Leukocyte Surface Markers and Complement Activation With Heparin-Coated Cardiopulmonary Bypass
Ann. Thorac. Surg., January 1, 1997; 63(1): 105 - 111.
[Abstract] [Full Text]

Home page
 Ann. Thorac. Surg.Home page
H. t. Velthuis, P. G. M. Jansen, C. E. Hack, L. Eijsman, and C. R. H. Wildevuur
Specific Complement Inhibition With Heparin-Coated Extracorporeal Circuits
Ann. Thorac. Surg., April 1, 1996; 61(4): 1153 - 1157.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1990 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1990 by The American Association of Immunologists, Inc. All rights reserved.